Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection

This study aimed to investigate the impact of the ABCB1-rs1045642 gene polymorphism on the blood drug concentrations of voriconazole in patients with severe invasive fungal infections. A total of 101 patients treated with voriconazole were enrolled in this study. Polymerase chain reaction and Sanger...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Zhang, Xing Gao, Dongmei Lv
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1510890/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387745746616320
author Qian Zhang
Qian Zhang
Xing Gao
Dongmei Lv
author_facet Qian Zhang
Qian Zhang
Xing Gao
Dongmei Lv
author_sort Qian Zhang
collection DOAJ
description This study aimed to investigate the impact of the ABCB1-rs1045642 gene polymorphism on the blood drug concentrations of voriconazole in patients with severe invasive fungal infections. A total of 101 patients treated with voriconazole were enrolled in this study. Polymerase chain reaction and Sanger sequencing were used to detect the genotype of ABCB1-rs1045642, and enzyme amplified immunoassay was used to detect the plasma trough concentration of voriconazole. We analyzed the impacts of patient genotype and the minimum concentration of voriconazole as well as investigated the treatment efficacy and rates of adverse reactions in patients with different genotypes. All subjects received standard-dose voriconazole treatment for 1 week, and the mean plasma concentration was found to be 4.5 (3.10, 6.90) mg/L. Three genotypes of ABCB1-rs1045642 were found in the study cohort, namely, wild type (CC type), heterozygous mutant type (CT type), and homozygous mutant type (TT type). There were 18 TT, 48 CT, and 35 CC type cases. Patients with different genotype groups and varying plasma trough concentrations did not differ statistically significantly in terms of the treatment efficacy or incidence of adverse events. Voriconazole plasma concentrations differed significantly among patients of different genders and ABCB1-rs1045642 genotypes. By incorporating gender into the multiple regression model, the regression equations were obtained as C1 = 6.09–1.33×Gender (male = 0, female = 1)-0.47× X1 (X1: T/T = 1, non-T/T = 0) and C2 = 6.09–1.33×Gender (male = 0, female = 1)-0.94×X1 (X1: T/T = 1, non-T/T = 0). The ABCB1-rs1045642 genotype was not found to affect voriconazole plasma trough concentrations in patients with invasive fungal infections admitted to the intensive care unit.
format Article
id doaj-art-cc5dc27b8fcc4309ae8667d7fc6ff06a
institution Kabale University
issn 1663-9812
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-cc5dc27b8fcc4309ae8667d7fc6ff06a2025-08-20T03:44:24ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-03-011610.3389/fphar.2025.15108901510890Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infectionQian Zhang0Qian Zhang1Xing Gao2Dongmei Lv3Xuzhou Medical University, Xuzhou, ChinaSecond Affiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaAffiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaAffiliated Hospital of Xuzhou Medical University, Xuzhou, ChinaThis study aimed to investigate the impact of the ABCB1-rs1045642 gene polymorphism on the blood drug concentrations of voriconazole in patients with severe invasive fungal infections. A total of 101 patients treated with voriconazole were enrolled in this study. Polymerase chain reaction and Sanger sequencing were used to detect the genotype of ABCB1-rs1045642, and enzyme amplified immunoassay was used to detect the plasma trough concentration of voriconazole. We analyzed the impacts of patient genotype and the minimum concentration of voriconazole as well as investigated the treatment efficacy and rates of adverse reactions in patients with different genotypes. All subjects received standard-dose voriconazole treatment for 1 week, and the mean plasma concentration was found to be 4.5 (3.10, 6.90) mg/L. Three genotypes of ABCB1-rs1045642 were found in the study cohort, namely, wild type (CC type), heterozygous mutant type (CT type), and homozygous mutant type (TT type). There were 18 TT, 48 CT, and 35 CC type cases. Patients with different genotype groups and varying plasma trough concentrations did not differ statistically significantly in terms of the treatment efficacy or incidence of adverse events. Voriconazole plasma concentrations differed significantly among patients of different genders and ABCB1-rs1045642 genotypes. By incorporating gender into the multiple regression model, the regression equations were obtained as C1 = 6.09–1.33×Gender (male = 0, female = 1)-0.47× X1 (X1: T/T = 1, non-T/T = 0) and C2 = 6.09–1.33×Gender (male = 0, female = 1)-0.94×X1 (X1: T/T = 1, non-T/T = 0). The ABCB1-rs1045642 genotype was not found to affect voriconazole plasma trough concentrations in patients with invasive fungal infections admitted to the intensive care unit.https://www.frontiersin.org/articles/10.3389/fphar.2025.1510890/fullABCB1-rs1045642gene polymorphisminheritancevoriconazoleblood concentrationinvasive fungal infection
spellingShingle Qian Zhang
Qian Zhang
Xing Gao
Dongmei Lv
Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
Frontiers in Pharmacology
ABCB1-rs1045642
gene polymorphism
inheritance
voriconazole
blood concentration
invasive fungal infection
title Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
title_full Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
title_fullStr Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
title_full_unstemmed Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
title_short Influence of the ABCB1-rs1045642 gene polymorphism on blood drug concentration in voriconazole-treated patients with severe invasive fungal infection
title_sort influence of the abcb1 rs1045642 gene polymorphism on blood drug concentration in voriconazole treated patients with severe invasive fungal infection
topic ABCB1-rs1045642
gene polymorphism
inheritance
voriconazole
blood concentration
invasive fungal infection
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1510890/full
work_keys_str_mv AT qianzhang influenceoftheabcb1rs1045642genepolymorphismonblooddrugconcentrationinvoriconazoletreatedpatientswithsevereinvasivefungalinfection
AT qianzhang influenceoftheabcb1rs1045642genepolymorphismonblooddrugconcentrationinvoriconazoletreatedpatientswithsevereinvasivefungalinfection
AT xinggao influenceoftheabcb1rs1045642genepolymorphismonblooddrugconcentrationinvoriconazoletreatedpatientswithsevereinvasivefungalinfection
AT dongmeilv influenceoftheabcb1rs1045642genepolymorphismonblooddrugconcentrationinvoriconazoletreatedpatientswithsevereinvasivefungalinfection